Concomitantly with decreased miR–129-5p expression in CF, we found that the expression of miR–129-5p targets SOX9 (Figure 2D) and ASPN (Figure 2E) in CF was upregulated in LV in patients with HF compared with controls, as assessed by immunofluorescence. Here, ASPN is linked to cystic fibrosis.